Метою даного дослідження було вивчення вірогідного впливу річного курсу компенсації дефіциту обміну 25(OH)D за допомогою офіцинального препарату вітаміну D на якість життя хворих із множинним склерозом. Проаналізовано дані спостереження за 57 пацієнтами з множинним склерозом. Через 1 рік у групі вітаміну D3 установлено значуще покращення оцінки загального сприйняття здоров’я (р = 0,002), життєздатності (р = 0,003), ролі емоційних проблем в обмеженні життєдіяльності (р = 0,01), показника психічного здоров’я (р = 0,008). Застосування вітаміну D3 позитивно позначилося на психічному компоненті якості життя.
Funding Acknowledgements
Type of funding sources: None.
Background
Arrhythmia is among the most common and severe myocardial infarction complications. Myeloperoxidase as an important immune factor can be linked to atrial fibrillation (AF) development. Previous studies indicated myeloperoxidase (MPO) as a significant mortality predictor in ST-segment elevation myocardial infarction (STEMI). The MPO role in prognosis for adverse clinical outcomes, as atrial fibrillations in STEMI patients remains not fully understood.
The purpose of the investigation was to examine the MPO in prognosis of adverse outcomes presented by atrial fibrillations in patients with STEMI.
Methods
The study included 233 STEMI patients, 112 males, 121 females, and average age 67.87±7.11 years. Follow-up period was 14 days. Adverse outcome was observed and included atrial fibrillations. Plasma MPO levels were determined by ELISA, MPO was collected on admission.
Results
Patients with indicated adverse effects showed significantly increased MPO levels compared to those without ones, 169.91 IQR [89.45; 201.98] ng/ml vs 81.4 [33.91;181.29] ng/ml; p < 0.001. A ROC analysis determined a MPO cut-off value for arrhythmia (AF) development of 176.53 ng/ml with a sensitivity of 71.1% and specificity of 77.6%, AUC 0.732; 95 % CI 0.677-0.782; p <0.001. Elevated MPO concentration was a significant predictor for AF (OR 1.115; 95% CI: 1.007-1.841; p<0.001). Even adjusted for age and sex MPO remained significantly predictive for arrhythmia development.
Conclusions
The study suggests that increased levels of MPO are associated with the higher risk of atrial fibrillation. MPO could be a possible significant factor for therapy optimization in high-risk STEMI patients.
The study included 258 (96 males, 162 females) of patients in the age of 52.2±14.16 years with pain in the lumbar-sacral part of spine due to degenerative-dystrophic changes. Among them: 30 patients received medication treatment (group 1, control), 114 transforaminal epidural block (group 2) and 114 — caudal epidural blockades (group 3, n = 114). Period of observation was 6 months. The assessment of the intensity of the pain was performed on the visual analog scale (VAS), the quality of life — on the Oswestry Disability Index (ODI) and the Short Form Health Survey-36 (SF-36). Caudal and transforaminal epidural blockades could effectively reduce the intensity of pain (p<0.05). 98.2% of patients reported regression of pain immediately after caudal epidural blockades, but the positive result remained during 6 months after procedure in only 59.6% of patients. Transforaminal epidural block contributed to a significant decrease the intensity of pain according to the VAS in the whole group and different monitoring periods in 76.4–91.2% of patients. Both methods are effective for treatment of the lumbar pain syndrome and are associated with a positive dynamic of patient quality of life. However, caudal epidural blockades are more effective in the short term.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.